Search research articles
Contact Us
Filters
Showing results (81-90 of 183) with videos related to
Page
of 19
Sort By:
Urologic Oncology
|
June 7, 2021
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer
Daniel M Geynisman, Jodi K Maranchie, Mark W Ball, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov Website
Pooja Ghatalia, Rebecca Koenigsberg, David Pisarcik, et al.
Pharmacoeconomics
|
May 14, 2014
Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review
Fabrice Smieliauskas, Chun-Ru Chien, Chan Shen, et al.
Pharmacoeconomics
|
November 24, 2018
Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review
Chun-Ru Chien, Daniel M Geynisman, Bumyang Kim, et al.
Nature Reviews. Nephrology
|
April 15, 2015
The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease
Tamina Seeger-Nukpezah, Daniel M Geynisman, Anna S Nikonova, et al.
Urologic Oncology
|
July 20, 2017
Role of collaboration between urologists and medical oncologists in the advanced prostate cancer space
Chethan Ramamurthy, Jamie Doyle, Robert G Uzzo, et al.
Urology
|
April 5, 2017
Malignant Infiltration of the Penis From Urothelial Carcinoma of the Bladder
Carmen Tong, Nikolas Daskalakis, Daniel C Edwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2015
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011
Ya-Chen Tina Shih, Fabrice Smieliauskas, Daniel M Geynisman, et al.
Clinical Genitourinary Cancer
|
May 20, 2025
Impact of Renal Function Eligibility Criteria on Clinical Trials and Real-World Survival Outcomes Among Patients With Metastatic Renal Cell Carcinoma
Xiaoliang Wang, Jill Hasler, Benjamin Miron, et al.
European Urology Focus
|
July 30, 2017
Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer
Philip Abbosh, Srinath Sundararajan, Sherri Z Millis, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 183) with videos related to
Sort By:
Page
of 19
Urologic Oncology
|
June 7, 2021
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer
Daniel M Geynisman, Jodi K Maranchie, Mark W Ball, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov Website
Pooja Ghatalia, Rebecca Koenigsberg, David Pisarcik, et al.
Pharmacoeconomics
|
May 14, 2014
Cost-effectiveness analyses of targeted oral anti-cancer drugs: a systematic review
Fabrice Smieliauskas, Chun-Ru Chien, Chan Shen, et al.
Pharmacoeconomics
|
November 24, 2018
Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review
Chun-Ru Chien, Daniel M Geynisman, Bumyang Kim, et al.
Nature Reviews. Nephrology
|
April 15, 2015
The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease
Tamina Seeger-Nukpezah, Daniel M Geynisman, Anna S Nikonova, et al.
Urologic Oncology
|
July 20, 2017
Role of collaboration between urologists and medical oncologists in the advanced prostate cancer space
Chethan Ramamurthy, Jamie Doyle, Robert G Uzzo, et al.
Urology
|
April 5, 2017
Malignant Infiltration of the Penis From Urothelial Carcinoma of the Bladder
Carmen Tong, Nikolas Daskalakis, Daniel C Edwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2015
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011
Ya-Chen Tina Shih, Fabrice Smieliauskas, Daniel M Geynisman, et al.
Clinical Genitourinary Cancer
|
May 20, 2025
Impact of Renal Function Eligibility Criteria on Clinical Trials and Real-World Survival Outcomes Among Patients With Metastatic Renal Cell Carcinoma
Xiaoliang Wang, Jill Hasler, Benjamin Miron, et al.
European Urology Focus
|
July 30, 2017
Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer
Philip Abbosh, Srinath Sundararajan, Sherri Z Millis, et al.
Page
of 19